During an investment briefing in Washington, DC, Elania Luk, director of the Hong Kong Economic and Trade Office (HKETO), emphasized Hong Kong’s position as the world’s second-largest biotech funding hub, following New York. She highlighted the region’s strong educational landscape, featuring five top global universities and support from various innovation zones. The briefing showcased opportunities in Hong Kong’s life and health sciences sector, with a focus on research and development initiatives and collaborative schemes that have backed numerous projects. The event was attended by diverse stakeholders, underscoring Hong Kong’s role as a global hub for biotechnology and innovation.
Disclaimer: This summary is written by AI, which can make mistakes. Please follow up on any news information from additional sources.
Link to original article source: https://www.chinadailyasia.com/article/632569
